VentriPoint Diagnostics Ltd. (VPTDF) Expands Target Market to Include Pulmonary Hypertension
A unique ultrasound-based system for performing right heart analysis, developed by VentriPoint Diagnostics and now used in various hospitals around the world, is also being developed and introduced as a superior approach to diagnose pulmonary hypertension (PH), an unhealthy increase in blood pressure in the pulmonary artery or pulmonary vein which can lead to a variety of problems, up to and including heart failure. The VentriPoint VMS system, called Angelo, uses 2-dimensional ultrasound data, together with a patented system called Knowledge-Based Reconstruction (KBR) for analyzing that ultrasound data. The result is an information-rich 3-dimensional model of the heart. For right…